Greater Occipital Nerve (GON) Block Effectivity in the Treatment of Chronic Migraine: 6 Months Follow up

NCT02578719 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2018-01-23

No results posted yet for this study

Summary

This study evaluates effectiveness of greater occipital nerve blocks with bupivacaine compared to placebo in chronic migraine patients.

Conditions

  • Migraine Disorders

Interventions

DRUG

bupivacaine

marcaine %0.5 20 ml flacon

DRUG

saline

%0.9 sodium chloride

Sponsors & Collaborators

  • Bozok University

    lead OTHER

Principal Investigators

  • Levent E Inan, Prof. · Bozok University Neurology Department

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-07-31
Primary Completion
2018-07-31
Completion
2018-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02578719 on ClinicalTrials.gov